Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology - Podcasts

00:47:20

Reframing Multiple Sclerosis as a Spectrum of...

Weekly Neurology Deep Dive - A review of recent... ·

2026/10/04

This academic review proposes a unified spectrum model for multiple sclerosis (MS) that challenges traditional, rigid phenotype classifications like RRMS, SPMS, and PPMS. The authors argue that disability often accumulates through progression independent of relapse activity (PIRA) and "smouldering" disease processes, which frequently occur silently long before a formal progressive diagnosis. By integrating the role of neurologic reserve and biological ageing, the text explains how the clinical

en

00:52:18

Extended Version - Examination and Localization of...

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/27

This epiode is an extended version of the recently published episode on the examination and localization of eye movement disorders. The orginal paper details a comprehensive clinical framework for the examination and localization of eye movement disorders, emphasizing that the systematic bedside assessment serves as the primary tool for anatomical diagnosis. By distinguishing between supranuclear, nuclear, and infranuclear lesions, clinicians can categorize ocular motor dysfunction based on how

en

00:45:59

Guidance for Applying the 2024 McDonald Criteria for...

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/27

This episode is a comprehensive review of a peper exploring the 2024 McDonald criteria, which represent a significant update to the global standards for diagnosing multiple sclerosis (MS). These revisions aim to facilitate earlier diagnosis and improve clinical outcomes by incorporating new paraclinical tools, such as optic nerve imaging, central vein sign, and kappa free light chains. For the first time, the criteria provide formal diagnostic pathways for asymptomatic individuals and those with

en

00:17:23

Anti-Amyloid Antibodies for Alzheimer’s Disease:...

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/20

This umbrella review evaluates the clinical efficacy and safety of two recently approved anti-amyloid antibodies, lecanemab and donanemab, for treating early-stage Alzheimer’s disease. By synthesizing data from eleven high-quality systematic reviews and meta-analyses, the authors conclude that these drugs successfully reduce brain amyloid burden and provide a statistically significant slowing of cognitive decline. However, the text highlights a critical concern: the observed cognitive benefits often

en

00:24:40

Examination and Localization of Eye Movement Disorders

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/20

This paper provides a comprehensive clinical framework for the examination and localization of eye movement disorders, emphasizing that the systematic bedside assessment serves as the primary tool for anatomical diagnosis. By distinguishing between supranuclear, nuclear, and infranuclear lesions, clinicians can categorize ocular motor dysfunction based on how specific eye movements, such as saccades or the vestibulo-ocular reflex, are impacted. The sources outline essential quantitative bedside

en

00:17:48

Liquid Biopsy: Current Applications and Future Direction

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/13

This comprehensive review examines the evolution and clinical potential of liquid biopsy, a non-invasive diagnostic method that analyzes biomarkers within bodily fluids. The text classifies primary biomarkers such as circulating tumor DNA, intact tumor cells, and extracellular vesicles, while detailing the high-sensitivity technologies like digital PCR and next-generation sequencing used to detect them. In oncology, the authors highlight how these tools facilitate early cancer screening, the

en

00:17:34

Palasma Exchange in Autoimmune Neurological Diseases

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/13

This systematic review and meta-analysis evaluates the effectiveness and safety of therapeutic plasma exchange (TPE) for treating autoimmune neurological diseases (ANDs). By analyzing 38 studies involving 2,199 patients, the research indicates that TPE leads to a high rate of clinical improvement across various conditions, including Guillain-Barré syndrome and myasthenia gravis. While age appears to influence the success rate—with younger patients showing better responses than those over

en

00:22:45

Parsonage-Turner Syndrome: A Comprehensive Clinical...

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/13

Parsonage-Turner syndrome, also known as neuralgic amyotrophy, is a frequently misdiagnosed peripheral nerve disorder characterized by sudden, intense shoulder pain followed by muscle weakness and atrophy. While historically considered a rare and temporary condition, contemporary research reveals it is far more prevalent and can cause long-term disability and persistent fatigue. The condition is believed to be immune-mediated, often triggered by infections, physical trauma, or genetic

en

00:11:25

Neurological Involvement in Merkel Cell Carcinoma

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/07

This clinical review examines the neurological complications associated with Merkel cell carcinoma (MCC), distinguishing between immune-mediated paraneoplastic syndromes and direct metastatic involvement. The text highlights that Lambert–Eaton myasthenic syndrome (LEMS) is the most frequent paraneoplastic manifestation and often appears before the cancer is officially diagnosed. Diagnostic protocols emphasize the use of paired serum and CSF antibody testing, specifically looking for VGCC, anti-Hu,

en

00:11:09

Myopathy in Anti-IgLON5 Disease, An ALS Mimic

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/07

The provided research investigates how anti-IgLON5 disease, a neurological disorder, frequently manifests through neuromuscular symptoms such as proximal limb weakness, muscle wasting, and fasciculations. By examining a cohort of Dutch patients, researchers discovered that over half exhibited signs of myopathy, a clinical feature previously underreported or misunderstood in this condition. Analysis of muscle biopsies revealed consistent abnormalities and a notable increase in IgLON5 protein

en

00:22:16

Lambert-Eaton Myasthenic Syndrome - A Clinical Review

Weekly Neurology Deep Dive - A review of recent... ·

2026/09/07

Lambert–Eaton myasthenic syndrome (LEMS) is a rare autoimmune condition that disrupts communication between nerves and muscles by blocking the release of acetylcholine. This clinical review highlights the disorder's signature triad of symptoms, which includes leg-heavy weakness, diminished reflexes, and autonomic issues like dry mouth. A critical aspect of the text is the link between LEMS and small-cell lung cancer, noting that the neurological symptoms often serve as a preliminary warning for

en

00:21:56

Anti-CD20 Therapy Safety and Outcomes in Pregnancy

Weekly Neurology Deep Dive - A review of recent... ·

2026/08/30

Recent clinical reviews and real-world registry data indicate that anti-CD20 monoclonal antibodies are generally safe for women of reproductive age managing multiple sclerosis and other autoimmune conditions. Because these drugs do not significantly cross the placenta until the second trimester, exposure during the preconception period or early pregnancy does not appear to increase the risk of congenital malformations. While infants exposed later in gestation may experience transient B-cell

en

00:09:16

Neuronal Antibodies in Atypical Parkinsonism Clinical...

Weekly Neurology Deep Dive - A review of recent... ·

2026/08/30

Researchers investigated the prevalence of neuronal antibodies in over five hundred patients initially diagnosed with atypical parkinsonian syndromes. The study found that only a small fraction, approximately 1.3%, actually suffered from antibody-associated disorders rather than neurodegenerative diseases. While certain conditions like anti-IgLON5 disease can mimic parkinsonism, they often present with distinct red flags such as sleep apnea or neuromuscular symptoms. Because these autoimmune cases

en

00:18:59

Anticoagulation in Atrial Fibrillation with Prior...

Weekly Neurology Deep Dive - A review of recent... ·

2026/08/23

This research article presents a systematic review and meta-analysis evaluating the use of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation who have previously suffered an intracranial hemorrhage. Analyzing data from five large observational studies, the authors found that DOACs are associated with a reduced risk of recurrent bleeding, ischaemic stroke, and all-cause mortality compared to traditional blood thinners. However, the study notes

en

00:20:35

Predictors of Fatigue Trajectories in Multiple Sclerosis

Weekly Neurology Deep Dive - A review of recent... ·

2026/08/23

This study investigates how fatigue levels change over time for individuals with relapsing-remitting multiple sclerosis. Researchers identified three distinct patterns for both physical and cognitive exhaustion, ranging from patients who improved to those whose symptoms significantly worsened. The analysis revealed that a smaller cervical spinal cord area serves as the most reliable biological indicator for predicting an increase in fatigue. Additionally, the length of time spent on

en

00:57:24

Diagnosis of Purely Lower Motor Neuron Syndromes

Weekly Neurology Deep Dive - A review of recent... ·

2026/08/09

This review by Dr. Amer Ghavanini provides a systematic framework for diagnosing purely lower motor neuron (LMN) syndromes, which are clinical presentations defined by muscle wasting and weakness without sensory loss. While often associated with fatal neurodegenerative conditions like amyotrophic lateral sclerosis (ALS), the text emphasizes that many LMN presentations stem from treatable mimics such as multifocal motor neuropathy, infectious diseases like Lyme, or toxic exposures. The author details

en

00:12:20

Quality of Care Delivered by International Medical...

Weekly Neurology Deep Dive - A review of recent... ·

2026/07/26

This study investigated whether international medical graduates (IMGs) practicing in Canada face a higher level of medicolegal risk compared to those who studied in Canada or the United States. By analyzing extensive data from the Canadian Medical Protective Association, researchers assessed both the frequency of civil legal actions and the specific outcomes of those cases. The results demonstrated that there is no significant difference between these groups regarding the likelihood of being sued or

en

00:10:41

Neuropsychiatric Risks of Anti-Seizure Medications

Weekly Neurology Deep Dive - A review of recent... ·

2026/07/20

This systematic review and meta-analysis evaluates the connection between anti-seizure medications (ASMs) and neuropsychiatric adverse events in patients with epilepsy. By analyzing 18 observational studies, researchers examined how different drug generations impact mental health, focusing on side effects like depression, psychosis, and cognitive impairment. The findings indicate that while first-generation drugs often correlate with memory issues, certain newer medications like topiramate and

en

00:18:03

Neurostimulation for Drug-Resistant Epilepsy

Weekly Neurology Deep Dive - A review of recent... ·

2026/07/20

This systematic review and meta-analysis evaluates the effectiveness and safety of responsive neurostimulation (RNS) in children with drug-resistant epilepsy. By analyzing 39 studies involving over 400 patients, the researchers found that approximately two-thirds of pediatric patients experienced a reduction in seizure frequency of at least 50%. While total seizure freedom remains rare at roughly 3%, this outcome improved significantly with longer follow-up durations, suggesting that the brain

en

00:24:25

Multidisciplinary Care for Fragile X-Associated...

Weekly Neurology Deep Dive - A review of recent... ·

2026/07/13

This review article describes Fragile X-associated tremor/ataxia syndrome (FXTAS), a progressive neurodegenerative condition affecting individuals with a specific genetic premutation. It details how the disorder typically manifests in older adults through motor impairments, such as tremors and balance issues, alongside cognitive decline and psychiatric symptoms like anxiety. The authors explain the underlying RNA toxicity and genetic mechanisms that distinguish FXTAS from other Fragile X-related

en

Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Healthy Chat

DR ALI BANIHAMOUR

Dingue ‐ RTS

RTS - Radio Télévision Suisse

Words of Wellness with Shelly

Shelly Jefferis

Linchpin Conversations

Pat Sherwood